Rigel Pharmaceuticals Inc. Q2 Loss Decreases, Beats Estimates

August 06, 2024 — 04:06 pm EDT

Written by RTTNews.com for RTTNews

(RTTNews) - Rigel Pharmaceuticals Inc. (RIGL) revealed Loss for second quarter that decreased from the same period last year and beat the Street estimates.

The company's earnings totaled -$1.030 million, or -$0.06 per share. This compares with -$6.600 million, or -$0.38 per share, in last year's second quarter.

Analysts on average had expected the company to earn -$0.29 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 37.0% to $36.841 million from $26.886 million last year.

Rigel Pharmaceuticals Inc. earnings at a glance (GAAP) :

-Earnings (Q2): -$1.030 Mln. vs. -$6.600 Mln. last year. -EPS (Q2): -$0.06 vs. -$0.38 last year. -Revenue (Q2): $36.841 Mln vs. $26.886 Mln last year.

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Rigel Pharmaceuticals Inc. Q2 Loss Decreases, Beats Estimates

Tags

Latest Articles